Potential new tool for cervical cancer detection and diagnosis
12/20/2014
Cervical cancer is, in many ways, a shining example of how successful the war on cancer can be. Thanks largely to the advent of Pap smear screening, U.S.
New colorectal cancer risk factor identified
12/19/2014
Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers.
Researchers shed light on how diet influences cancer development
12/19/2014
Researchers find that switching from a low- to high-calorie diet can either reduce tumor growth or encourage it, depending on when the dietary change is made.
Cancer genes contribute to congenital disorders
12/19/2014
Cancer genes may also be responsible for the development of congenital disorders.
People with low numeracy feel negative about taking part in bowel cancer screening
12/19/2014
PEOPLE who have problems with numbers may be more likely to feel negative about bowel cancer screening, including fearing an abnormal result, while some think the test is disgusting or embarrassing...
Annals of Internal Medicine news
12/19/2014
1. Earlier detection could close the race gap on colon cancer deathsRacial disparities in colon cancer survival rates may be explained by overall health at the time of diagnosis rather than...
Cancer can't grow if cells can't move
12/19/2014
By blocking a widespread enzyme, Centenary researchers have shown they can slow down the movement of cells and potentially stop tumours from spreading and growing.
Networks of genetic changes across cancers identified by algorithm
12/19/2014
Cancers often involve far more than a genetic mutation acting alone. Multiple mutations, many of which are rare, may occur in different networks of multiple genes.
Scientists link proteins that keep cells multiplying to cancer
12/18/2014
Researchers find a family of RNA-binding proteins known as Musashi proteins - that can change and lock cells into a proliferative state - may be involved in cancer regulation.
FDA expands approved use of Cyramza to treat aggressive non-small cell lung cancer (NSCLC)
12/18/2014
The U.S. Food and Drug Administration has expanded the approved use of Cyramza (ramucirumab) to treat patients with metastatic non-small cell lung cancer (NSCLC).